JW001 - C&J Services

jw001JW Pharmaceutical has presented positive preclinical data on JW0061, a novel Wnt-targeted hair loss treatment, at the U.S. Society of Investative Dermatology meeting. What are Wnt-Targeted Hair LossJw001 Mewujudkan sinergi antar Satuan Kerja Perangkat Daerah SKPD dalam rangka meningkatkan pelaporan keuangan yang baik dan tepat waktu. JW001. LINK JW001.